Revenue segments as reported by the company.

Total Oral, Personal and Home Care

Pet Nutrition

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative expenses

Other (income) expense, net

Goodwill and indefinite-lived intangible impairment charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Colgate-Palmolive

Ajax is a brand of cleaning products of Colgate-Palmolive.

Ajax

Speed Stick is a brand of deodorant/antiperspirant that, as the name suggests, comes in stick form. The product is owned by its parent company, Colgate-Palmolive. It was formerly known as "Mennen Speed Stick" prior to Colgate-Palmolive's purchase of The Mennen Company. Currently, the products feature the words "by Mennen" in a small font on the label. Speed Stick comes in both deodorant and antiperspirant forms. Speed Stick is both a sponsor and the official antiperspirant of the NHL.

Speed Stick

Irish Spring is the brand name of a deodorant soap, first marketed by the Colgate-Palmolive company in 1970. Irish Spring currently has nine variants.

Irish Spring

Mennen is a brand owned in most parts of the world by the Colgate-Palmolive Company. Its most notable product, Mennen Speed Stick, with its fougère perfume and green wide stick, was the market leader among deodorants and antiperspirants for men for many years.

Mennen

Softsoap is the trade name of Colgate-Palmolive's liquid hand soap and body wash.

Softsoap

Tom's of Maine is a brand name and manufacturing company of personal care products with only natural ingredients and a majority-owned subsidiary of Colgate-Palmolive since 2006. The company's products are intentionally made without ingredients that are chemically derived, environmentally damaging, or are tested on animals. While most of its products are vegan, some contain propolis and/or beeswax sourced from bees.

Tom's of Maine

Colgate-Palmolive Co. engages in the manufacturing and distribution of consumer products. It operates through the Oral, Personal, and Home Care and Pet Nutrition segments. The Oral, Personal, and Home Care segment includes toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. The Pet Nutrition segment offers specialty pet nutrition products manufactured and marketed by Hill’s Pet Nutrition. The company was founded by William Colgate in 1806 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Colgate-Palmolive reports robust Q4 growth and eyes future opportunities

Colgate-Palmolive's Q4 2022 earnings call highlighted strong organic sales growth and positive outlook for 2023.
The company faces challenges such as macroeconomic volatility, raw material costs, and cash flow concerns.
Opportunities lie in investments for future growth, margin improvement, and sustaining shareholder value.
Overall, Colgate-Palmolive remains focused on innovation, market share strength, and long-term success.

Colgate-Palmolive reports strong Q1 performance amidst inflation challenges

Colgate-Palmolive's Q1 performance was strong, with a focus on driving growth and improving margins. Despite challenges like inflation and competitive pressures, the company is leveraging strengths in innovation and brand equity to capitalize on opportunities in emerging markets and non-measured channels.

Colgate-Palmolive reports robust Q2 results and eyes emerging markets

Colgate-Palmolive's Q2 earnings call highlighted strong performance, balanced growth, and strategic focus on restoring gross margins.
The company remains confident in its strategies for consistent profitable growth and increasing shareholder value.
Opportunities in emerging markets and digital transformation are key drivers of future growth and competitiveness.

Colgate-Palmolive posts strong Q3 results, eyes sustained profitability and growth

Colgate-Palmolive's Q3 earnings call reflects a robust performance with a focus on sustainable profit growth and margin expansion. The company's strategic initiatives to address challenges and capitalize on opportunities position it well for future growth and market leadership.

Colgate-Palmolive reports robust performance in 2023, eyes balanced growth

Colgate-Palmolive's Q4 2023 earnings call highlighted strong performance, strategic focus on balanced growth, and opportunities for innovation-driven market expansion. The company faces challenges in managing market volatility and inflationary pressures but is well-positioned for growth. Leveraging strengths in market share, innovation, and strategic investments, Colgate-Palmolive aims for consistent earnings growth in 2024.

Colgate-Palmolive reports resilient Q1 performance and eyes global expansion

Colgate-Palmolive's Q1 2024 performance reflects resilience and strategic growth initiatives despite operational challenges.
Strong balance sheet, focus on innovation, and market expansion strategies position the company for sustainable growth.
Opportunities in Latin America, Europe, and emerging markets offer avenues for continued growth and market share expansion.
Emphasis on digital execution and value creation through innovation drive competitive advantage and market differentiation.

Colgate-Palmolive reports solid Q2 results, focuses on growth strategies

Colgate-Palmolive's Q2 call highlighted a strong performance, strategic focus on growth drivers, and challenges in pricing and consumer behavior. The company aims to leverage its strengths in innovation and brand presence to seize long-term opportunities.

Colgate-Palmolive reports robust Q3 results, eyes sustained growth strategies

Colgate-Palmolive's Q3 performance reflects a resilient business model with a strong focus on innovation and strategic investments.
Despite challenges in North America, the company's overall growth trajectory remains positive, driven by volume expansion and market adaptability.
Management's emphasis on sustained growth through strategic investments underscores a forward-looking approach to navigating market dynamics.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nearly 5 million bottles are being withdrawn due to "inadequate preservative," Colgate-Palmolive said.

Colgate-Palmolive Recalls Millions of Bottles of Fabuloso Over Bacteria Risk

The product may contain bacteria that's harmful to immunocompromised people.

Colgate Recalls Nearly 5 Million Bottles of Fabuloso Cleaner

Archer-Daniels-Midland Company

Allstate

Caterpillar

Coca-Cola

Kroger

Procter & Gamble

After a sharp downturn in 2022, investors may be looking for high-risk, high-reward equities to bank on as opposed to boring stocks to buy and hold forever. I get it. As some of the hottest names get cheaper, a temptation exists to pick them up for pennies on the dollar.

7 Boring Stocks to Buy and Hold Forever

Coinbase

CVS Health

Disney

Starbucks

Silvergate Capital Corp

With the Nasdaq nearly in a bull market (believe it or not), many companies reporting solid earnings, and the stock market coming off a scorching hot January, I'm very optimistic about stocks. But just as “there's always a bull market somewhere,” as CNBC's Jim Cramer loves to say, there are always overvalued stocks to sell.

7 Overvalued Stocks That Will Get Clobbered This Year

Henry Schein

CHICAGO--( BUSINESS WIRE )--The American Dental Association Foundation announces the 21st year of its Give Kids A Smile (GKAS) program, which officially launches today at this year's national kick-off event in St. Louis, MO where the program first began. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than seven million underserved children in the U.S. To learn more about the program's impact on helping improve oral health and total health over the years, click here to watch last year's 20th anniversary video.

American Dental Association Foundation Kicks Off the 21st Year of Give Kids A Smile® With Exclusive National Sponsors, Henry Schein and Colgate-Palmolive

Activision Blizzard

CME Group

Centene

Keurig Dr Pepper Inc

Paychex

Republic Services

Sysco

2022 has been a bad year for the equity market, with inflation and interest rates being the primary factors weighing on stocks throughout 2022.

10 Large Cap Stocks Trading Close to 52-Week Lows

Colgate-Palmolive (NYSE: CL) shares were corrected in January and hit new lows in the wake of the Q4 earnings report but this looks like a buyable bottom. An analyst is not only calling the bottom but the market is responding in kind.

Buying The Dip In Colgate-Palmolive

Colgate-Palmolive continues to show modest growth, but this is entirely driven by pricing, with volumes under continued pressure. This composition of growth weighs on margins as adjusted earnings have been stuck around the $3 per share mark for a while.

Colgate-Palmolive: Nothing To Smile About

NEW YORK--( BUSINESS WIRE )--Colgate-Palmolive Company today announced that Steve Cahillane, Chairman of the Board, President and Chief Executive Officer of Kellogg Company, has been elected to Colgate's Board of Directors effective February 1, 2023.

Colgate Elects Steve Cahillane to Board of Directors

AbbVie

Abbott Labs

Automatic Data Processing

Aflac

Cigna

Clorox

Cisco Systems

Emerson Electric

Intel

Illinois Tool Works

Johnson & Johnson

Lockheed Martin

Medtronic

Microsoft

QUALCOMM

Rio Tinto plc Sponsored

AT&T

UnitedHealth Group

Walgreens

Waste Management

Walmart

We present the 2022 year-end review of our eight-year-old Passive DGI-Core Portfolio. We consider this portfolio and strategy as the foundation of our overall portfolio. We will provide updates on changes, additional investments, dividends collected, and an overall 2022 performance.

The 4% DGI Core Portfolio: 2022 Year-End Review

Colgate-Palmolive Company (NYSE:CL ) Q4 2022 Earnings Conference Call January 27, 2023 8:30 AM ET Company Participants John Faucher - Chief Investor Relations Officer and Senior Vice President, M&A Noel Wallace - Chairman, President and CEO Stan Sutula - Chief Financial Officer Conference Call Participants Dara Mohsenian - Morgan Stanley Andrea Teixeira - JPMorgan Kaumil Gajrawala - Credit Suisse Chris Carey - Wells Fargo Securities Peter Grom - UBS Kevin Grundy - Jefferies Olivia Tong - Raymond James Nik Modi - RBC Capital Markets Jason English - Goldman Sachs Steve Powers - Deutsche Bank Rob Ottenstein - Evercore Mark Astrachan - Stifel Lauren Lieberman - Barclays Bryan Spillane - Bank of America Operator Good morning. Welcome to today's Colgate-Palmolive 2022 Fourth Quarter and Year End Earnings Conference Call.

Colgate-Palmolive Company (CL) Q4 2022 Earnings Call Transcript

Despite challenging macroeconomic conditions, gains from revenue growth management plans and continued momentum aid Colgate's (CL) Q4 results.

Colgate (CL) Earnings Meet Estimates in Q4, Sales Surpass

American Express

Chevron

Year over year, headline PCE came in at +5.0%, a half-point lower than November's +5.5%.

PCE Melts Gently Overall; AXP, CVX, CL Post Q4 Results

Although the revenue and EPS for Colgate-Palmolive (CL) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Colgate-Palmolive (CL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

As some CPG companies say private-label growth has stalled or reversed, Colgate sees its continuance. On a call with analysts Friday (Jan. 27) discussing the company's fourth-quarter 2022 financial results, consumer-packaged goods (CPG) giant Colgate-Palmolive noted that while trade-down to private label has flatlined in certain categories, it continues to grow in others.

Colgate-Palmolive Sees Trade-Down Continuing as Competitors Say Otherwise

Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 1.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Colgate-Palmolive (CL) Matches Q4 Earnings Estimates

Colgate-Palmolive Co.'s CL, -0.32% fourth-quarter results beat analysts' top and bottom-line expectations before market open Friday. The company earned 1 cents a share, compared with 18 cents a share in the year-ago quarter, impacted by goodwill and impairment charges related to the Filorga skin care business.

Colgate-Palmolive reports Q4 beat, despite ‘challenging macroeconomic conditions'

NEW YORK--( BUSINESS WIRE )--Colgate-Palmolive Company (NYSE:CL) today reported results for fourth quarter and full year 2022. Noel Wallace, Chairman, President and Chief Executive Officer, commented, “We are very pleased to have finished 2022 with a continuation of our strong growth momentum, as 2022 was our fourth consecutive year delivering organic sales growth at or above our 3% to 5% long-term targeted range. Net sales increased 5.0% in the fourth quarter, and organic sales grew 8.5% with growth in every division and in all four of our categories, despite challenging macroeconomic conditions worldwide.

Colgate Announces 4th Quarter and Full Year 2022 Results

Colgate's (CL) Q4 results are expected to reflect gains from strong consumer demand, innovation, brand strength, and focus on premiumization and digital transformation.

Here's Why Colgate (CL) is Well-Poised for Earnings Beat in Q4

ABM Industries

American States Water

Becton, Dickinson and Co.

Black Hills

Commerce Bancshares

Cincinnati Financial

Dividend Kings have an astounding track record of 50 or more years of higher dividend payouts. I rank the Dividend Kings using Quality Snapshots, a simple yet elegant system for assessing the quality of dividend growth stocks.

News for Colgate-Palmolive Stock (CL)